Cargando…
The changing role of surgery in metastatic non-seminomatous germ cell tumour.
In the last 2 years (1989-1990) we have treated a total of 53 patients with metastatic nonseminomatous germ cell tumours (teratoma). In ten cases surgery to remove residual abdominal masses was required on completion of chemotherapy and normalisation of tumour markers (HCG and AFP). In a further thr...
Autores principales: | Cassidy, J., Lewis, C. R., Kaye, S. B., Kirk, D. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1992
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977340/ https://www.ncbi.nlm.nih.gov/pubmed/1370759 |
Ejemplares similares
-
Surgery in metastatic non-seminomatous germ cell tumours.
por: Tobias, J. S.
Publicado: (1992) -
Improving the outcome of salvage treatment for non-seminomatous germ cell tumours (NSGCT)
por: Bono, J S de, et al.
Publicado: (2000) -
Frequency of serum tumour marker monitoring in patients with non-seminomatous germ cell tumours.
por: Seckl, M. J., et al.
Publicado: (1990) -
The epidemiology of non-seminomatous germ cell tumours in the west of Scotland 1975-89.
por: Harding, M., et al.
Publicado: (1995) -
Results of treatment of non seminomatous germ cell tumours; 122 consecutive cases in the West of Scotland, 1981-1985.
por: Graham, J., et al.
Publicado: (1988)